Clinical Trial Update: Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a reduced dexamethasone pre-medication dose in elderly patients receiving weekly docetaxel; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lung Cancer

Drugs mentioned

• Decadron (Dexamethasone)
• Taxotere (docetaxel)

Snippet

Sponsor: Geriatric Oncology Consortium | Conditions: Breast Cancer, Lung Cancer | Phase 2 | Status: TERMINATED